Publications by authors named "Satoshi Saida"

Claim this Profile
M
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection.
Ryo Akazawa, Takashi Mikami, Masaki Yamada, Itaru Kato, Hirohito Kubota, Satoshi Saida

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
Yuta Katai, Tatsuya Kamitori, Satoshi Saida, Yoshinori Uchihara, Ryo Akazawa

Cancer Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pluripotent stem cell model of Emberger syndrome reveals reduced lymphatic endothelial differentiation.
Kagehiro Kouzuki, Katsutsugu Umeda, Takayuki Hamabata, Tatsuya Kamitori, Takashi Mikami, Satoshi Saida

Int J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Immune Thrombocytopenia and Autoimmune Neutropenia in a 4-Year-Old Male Patient With XIAP Deficiency: A Case Report.
Kentaro Yoshikawa, Kazusi Izawa, Yukako Maeda, Chiaki Tao, Shuhei Karakawa, Satoshi Saida

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report.
Toru Nagata, Hirohito Kubota, Itaru Kato, Kazushi Izawa, Ryo Akazawa, Satoshi Saida

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply to Saraei and Hosseini.
Daichi Torizuka, Megumi Uto, Katsutsugu Umeda, Tatsuya Kamitori, Atsushi Iwai, Satoshi Saida

Int J Radiat Oncol Biol Phys· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful venetoclax and azacitidine treatment in pediatric acute myeloid leukemia associated with familial platelet disorder.
Rikako Tsukamoto, Shuro Nishio, Satoshi Saida, Tatsuya Kamitori, Kazuki Mitani

Pediatr Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.
Yoshinori Uchihara, Katsutsugu Umeda, Yosuke Yamada, Hiroaki Ito, Keiji Tasaka, Satoshi Saida

Cancer Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan.
Dan Tomomasa, Tasuku Suzuki, Ichiro Takeuchi, Kimitoshi Goto, Shin-Ichiro Hagiwara, Satoshi Saida

J Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency.
Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima

Pediatr Blood Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile xanthogranuloma manifesting with LCH-associated neurodegenerative disease-like radiological findings.
Tomoo Daifu, Katsutsugu Umeda, Atsushi Yokoyama, Takeshi Yoshida, Satoshi Saida

Pediatr Blood Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.
Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, Rika Kanezaki, Kiminori Terui, Satoshi Saida

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Scalp Dose Threshold for Preventing Permanent Alopecia in Scalp-Avoidance Whole-Brain Irradiation With Volumetric Modulated Arc Radiation Therapy for Pediatric Patients With Medulloblastomas.
Daichi Torizuka, Megumi Uto, Katsutsugu Umeda, Tatsuya Kamitori, Atsushi Iwai, Satoshi Saida

Int J Radiat Oncol Biol Phys· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose carboplatin-irinotecan-temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma.
Hirokazu Kobushi, Satoshi Saida, Katsutsugu Umeda, Atsushi Iwai, Kagehiro Kozuki

Pediatr Blood Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second relapse of FLT3-ITD-positive acute myeloid leukemia after discontinuation of 3-year post-transplant maintenance therapy with gilteritinib.
Keiji Tasaka, Itaru Kato, Shunki Takeshita, Yu Yoshioka, Ayuko Usami, Satoshi Saida

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful sequential therapy with rituximab and daratumumab for refractory posttransplant immune thrombocytopenic purpura.
Yuki Shino, Katsutsugu Umeda, Yoshinori Uchihara, Kazuki Mitani, Keiji Tasaka, Satoshi Saida

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cabozantinib to Treat MET -amplified Pediatric Colorectal Cancer.
Sadahiro Fukui, Katsutsugu Umeda, Hirohito Kubota, Atsushi Iwai, Ryo Akazawa, Satoshi Saida

J Pediatr Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients With Osteosarcoma Experiencing Relapse or Progression: A Single-institute Experience.
Katsutsugu Umeda, Akio Sakamoto, Takashi Noguchi, Yoshinori Uchihara, Hirokazu Kobushi, Satoshi Saida

J Pediatr Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Recovery With Chromosomal Abnormalities After Unrelated Umbilical Cord Blood Transplantation With Myeloablative Conditioning in a Case of Pediatric Acute Lymphoblastic Leukemia.
Yoshinori Uchihara, Itaru Kato, Ryo Hanaki, Satoshi Saida, Shotaro Iwamoto

J Pediatr Hematol Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation.
Naoko Kawabata, Hidefumi Hiramatsu, Takashi Mikami, Ryo Akazawa, Kuniaki Tanaka, Satoshi Saida

Pediatr Blood Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immature teratoma of the ovary associated with Cowden syndrome.
Kagehiro Kouzuki, Katsutsugu Umeda, Hidenori Kawasaki, Kiyotaka Isobe, Ryo Akazawa, Satoshi Saida

Pediatr Blood Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy.
Tomoyasu Jo, Satoshi Yoshihara, Asuka Hada, Yasuyuki Arai, Toshio Kitawaki, Satoshi Saida

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
Koji Nakajima, Hirohito Kubota, Itaru Kato, Kiyotaka Isobe, Hiroo Ueno, Satoshi Saida

Cancer Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Multimodal Therapy Combined With Long-term Temozolomide and Etoposide Treatment for Recurrent Osteosarcoma to the Liver and Stomach.
Katsutsugu Umeda, Kojiro Taura, Itaru Kato, Satoshi Saida, Hidefumi Hiramatsu

J Pediatr Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis